How Long Does Pazopanib — Take to Work?

No. The drug's effect on the tumour is not something you can feel. Pazopanib works by disrupting the blood supply to the tumour — a process that happens at a cellular and vascular level. What you may feel are side effects: fatigue, blood pressure changes, loose motions, or hair lightening. These tell you the drug is biologically active, but they are not a gauge of anti-tumour response. The scan at 8 to 12 weeks is the first real signal of whether the treatment is working.

Scanning too early is likely to be uninformative. Tumour changes on pazopanib accumulate gradually, and a scan at 4 or 6 weeks may not show a difference large enough to interpret reliably. There is also a phenomenon where a tumour can appear temporarily unchanged or slightly larger before the drug's effect becomes apparent — an early scan can misread this. The 8 to 12 week window is where imaging is most likely to give a clear, actionable result. Scanning earlier adds radiation exposure and cost without adding useful information.

Your oncologist is actively monitoring safety and tolerability throughout this period, not simply waiting for the scan. Blood tests check liver enzymes, kidney function, thyroid function, and blood counts — typically every few weeks at the start. Blood pressure is monitored and managed if elevated. Side effects are assessed and the dose may be adjusted if needed. The first scan answers the efficacy question; the weeks before it are about keeping you on the drug safely.

Missed doses disrupt the consistent drug levels that pazopanib depends on to maintain its effect on tumour blood vessels. This does not reset a clock in a precise way, but irregular dosing reduces the likelihood of a meaningful response. If you have missed doses because of side effects, tell your team rather than stopping the drug yourself — a dose reduction or a planned short break is often a better option than stopping entirely. If you have missed doses for another reason, let your team know so they can advise.

Planned breaks are sometimes used to manage cumulative side effects such as hand-foot skin reaction or severe fatigue. Whether this is appropriate for you, and for how long, is a clinical decision your oncologist will make based on your side effect profile and the current state of your disease. Do not stop or pause the drug without telling your team first. Restarting after a planned break is generally possible, but the timing and approach need to be managed carefully.

Several other agents are used after pazopanib, depending on your cancer type. In kidney cancer, other targeted agents and certain immunotherapy approaches have been used in this setting; in sarcoma, additional options exist that your oncologist will discuss with you. Progression on pazopanib does not mean you have run out of options — it means the treatment plan moves to the next step. The right sequence depends on your cancer type, your overall fitness, and what treatments you have already received.